As per the latest market research conducted by FMI, the global Radiotherapy Patient Positioning Accessories Market is expected to record a CAGR of 4.8% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of USD 619.5 million. By 2033, the valuation is anticipated to reach USD 993.6 million.
Radiotherapy patient positioning accessories are the tools used to accurately position and immobilize patients undergoing radiation therapy. These positioning accessories help to ensure that the radiation dose is delivered precisely to the tumor, while also protecting healthy tissue from damage.
Significant Growth Aspects:
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The radiotherapy patient positioning accessories market is expected to experience a healthy growth rate in the coming years. However, there are certain factors that can impede this growth and limit the potential of the market.
These factors include the high cost of radiotherapy equipment, lack of skilled professionals, and stringent government regulations. Also, the lack of awareness among healthcare personnel about the latest advancements in radiotherapy technology can also restrain the market growth.
Attributes | Value |
---|---|
Radiotherapy Patient Positioning Accessories Value (2022) | USD 588.8 million |
Radiotherapy Patient Positioning Accessories Market Expected Value (2023) | USD 619.5 million |
Radiotherapy Patient Positioning Accessories Market Forecast Value (2033) | USD 993.6 million |
Radiotherapy Patient Positioning Accessories Market Expected CAGR (2023 to 2033) | 4.8% |
Particulars | Details |
---|---|
H1, 2021 | 4.95% |
H1, 2022 Projected | 5.09% |
H1, 2022 Outlook | 4.99% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (+) 04 ↑ |
The global radiotherapy patient positioning accessories market is subject to market dynamics associated with macroeconomic and industry standards such as regulatory guidelines and product quality and safety assessment.
According to Future Market Insights' analysis, the global radiotherapy patient positioning accessories market expects to surge in value by 04 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to the H1-2022 Projected value, the market during the H1-2022 outlook period showed a dip of 10 BPS.
The growth of intensity-modulated radiation treatment, stereotactic body radiotherapy, and adaptive radiotherapy has resulted in an increase in the necessity for effective patient positioning, which is correlated with an increase in the observed BPS values.
The usage of immobilization devices during radiation for improved procedural outcomes is one of the significant industry breakthroughs.
However, as a result of the global lockdown measures implemented during the COVID-19 pandemic's onset, the reported reduction in BPS is linked to a relative decline in medical diagnostic and imaging operations. Hence, lower procedure rates have helped to bring down BPS levels.
The demand in the global radiotherapy patient positioning accessories market recorded a CAGR of 4.6% from 2018 to 2022. The sales of radiotherapy patient positioning accessories are estimated to grow by 1.6x between 2023 and 2033, reveals FMI.
A non-invasive cancer treatment method known as radiation therapy employs high-intensity waves or particles to eliminate cancerous cells.
Radiation patient positioning accessories are widely used to help patients keep their position comfortably since it is important for patients to retain their specific position during therapy to avoid issues. This is helping the market to expand.
Due to radiation therapy's fewer side effects and capacity to stop the regrowth of cancer cells, more and more people are switching from various cancer therapies like chemotherapy and surgery. This is driving up demand for equipment for patient positioning during radiation.
As per the latest market research conducted by FMI, the global radiotherapy patient positioning accessories market is expected to record a CAGR of 4.8% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of USD 619.5 million. By 2033, the valuation is anticipated to reach USD 993.6 million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
A major growth in the burden of cancer is being noticed over the previous few years, mainly to the growing alcohol intake, smoking, and others. For instance, the World Health Organization (WHO) estimates that more than 10 million new instances of cancer would be diagnosed worldwide in 2020.
To reduce the incidence and cancer-related deaths, governments in many nations are increasingly launching several cancer detection and treatment efforts. In order to encourage early cancer diagnosis, the Government of India announced the formation of the National Programme for Prevention & Control of Cancer, Diabetes, Cardiovascular diseases & Stroke (NPCDCS).
Many such initiatives in the United States, Germany, the United Kingdom, and China have significantly raised the rate of cancer diagnoses, spurring a rise in the use of cutting-edge cancer therapies like radiation. In the upcoming years, there is likely to be a high need for accessories for radiotherapy patient positioning as a result of this.
To Increase Sales of Radiotherapy Immobilization Devices, Patients' Preferences are being Shifted Towards Non-Invasive Treatments.
By 2033, the United Kingdom is anticipated to contribute significantly to sales in the Europe market, according to FMI, and is predicted to record a CAGR of 4.2% over the forecast period.
Due to its non-invasive nature and lack of side effects when compared to other therapies, advanced cancer treatments like radiation are becoming extremely popular throughout the United Kingdom, hence it is predicted that rising rates of obesity, smoking, alcoholism, nicotine addiction, and cancer is likely to increase demand for radiation immobilization tools such as locating & indexing bars, couch top & overlays, and others.
Favorable Government Early Diagnose Efforts to Drive Demand for Radiotherapy Patient Positioning Accessories
FMI estimates that the United States is likely to continue dominating the North American radiotherapy patient positioning accessories market over the forecast period. The market in the United States is expected to record a CAGR of 4.2% over the forecast period.
The government in the countries is launching several programs to reduce the fatalities brought on by cancer, such as putting up free screening camps, in response to the rising incidence of cancer and increasing awareness of the advantages of an early cancer diagnosis.
Due to this, there is a sharp increase in demand for radiation patient positioning accessories across the nation's installed base of radiotherapy systems.
Growth Outlook of Country-wise Insights:
Country | United States |
---|---|
CAGR (2018 to 2022) | 4.3% |
CAGR (2023 to 2033) | 4.2% |
Valuation (2033) | USD 273.7 million |
Country | United Kingdom |
---|---|
CAGR (2018 to 2022) | 4.4% |
CAGR (2023 to 2033) | 4.2% |
Valuation (2033) | USD 39.9 million |
Country | China |
---|---|
CAGR (2018 to 2022) | 7.9% |
CAGR (2023 to 2033) | 9.3% |
Valuation (2033) | USD 94.6 million |
Country | Germany |
---|---|
CAGR (2018 to 2022) | 5.4% |
CAGR (2023 to 2033) | 5.1% |
Valuation (2033) | USD 53.4 million |
Increasing Two-Step Radiation Treatment Adoption to Meet Need for Radiotherapy Patient Positioning Accessories
By 2023, sales of radiotherapy patient positioning accessories are expected to be dominated by the couch tops & overlays category, with more than 1/5 of the market, according to Future Market Insights.
In two-step radiation therapy, couch tops & overlays are frequently employed in diagnosis and imaging equipment, such as CT scans, to let patients relax in a specific position comfortably. As a result, the segment is growing because of the increasing use of two-step radiation therapy for accurately targeting malignant areas.
Increasing Medical Travel to Boost Sales of Radiation Treatment Immobilization Equipment
On the basis of end user, the global radiotherapy patient positioning accessories market is segmented into hospitals, radiation/proton therapy centers, and cancer research institutes. FMI states that the hospital segment is estimated to record a CAGR of 3.9% over the forecast period.
Radiation therapy immobilization device sales are being supported by rising medical tourism, which is increasing patient volume in cancer treatment centers. The segment's expansion is primarily facilitated by the presence of competent professionals, cutting-edge cancer diagnosis and treatment technology, and benevolent reimbursement policies in hospitals.
Leading companies in the global market for radiotherapy patient positioning accessories are utilizing inorganic tactics and forming strategic alliances, partnerships, mergers, and acquisitions with other market participants to broaden their reach internationally. For example,
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | USD million for Value |
Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Türkiye, Northern Africa, South Africa |
Key Segments Covered | Product Type, End User, and Region |
Key Companies Profiled | Bionix Radiation Therapy; CDR Systems; CIVCO Radiation; Orfit Industries N.V.; IZI Medical Products; Klarity Medical Products; Qfix, Elekta AB; Eckert & Ziegler BEBIG; Others |
Report Coverage | Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The market is projected to secure a valuation of USD 619.5 million in 2023.
From 2018 to 2022, the market registered a CAGR of 4.6%.
The market is expected to reach USD 993.6 million in 2033.
Shift in patients' preferences toward non-invasive treatments fueling the United Kingdom Market.
CDR Systems, CIVCO Radiation, Orfit Industries N.V. are the leading industry players.
Explore Healthcare Insights
View Reports